The standard colposcopes are expensive and bulky instruments, simply offering a magnified view of the women’s lower genital tract. Apart from the fact that standard colposcopes are not readily available in rural areas, standard colposcopes acquire limited diagnostic information, requiring high examiner’s expertise and a spectrum of in vitro diagnostic tests to reach a definitive diagnosis.

Our partner QCELL-a biophotonics imaging SME based in Greece-has developed a novel, low-cost, hand-held imaging spectroscopy-based colposcope,
integrating the most advanced spectral imaging and machine learning technologies. This novel imaging technology is intended to comprise a versatile, easy to use screening tool, capable of identifying cervical neoplasia and FGS,
instantly and non-invasively.